mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |